How low-cost drugs can succeed in the specialty pharmacy channel.
Charlie Bell
Advertisement
Articles by Charlie Bell
Advertisement
Latest Updated Articles
The ‘Spare-No-Expense’ AlternativePublished: September 13th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
2
Alkermes plc Acquiring Avadel Pharmaceuticals in $2.1 Billion Definitive Agreement
3
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
4
Moderna Ceases Development of mRNA-1647 After Failing to Reach Primary Goal in Clinical Trial
5
